SELLAS Life Sciences Group annual operating margin
2013
2014
2020
2021
2022
SELLAS Life Sciences Group's operating margin was −4,195.00% for fiscal 2022.
View full SELLAS Life Sciences Group company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | −4,195.00% | −3862.18 pp |
| 2021 | 2021-12-31 | −332.82% | +560.97 pp |
| 2020 | 2020-12-31 | −893.79% | −422.71 pp |
| 2014 | 2014-12-31 | −471.08% | +674.44 pp |
| 2013 | 2013-12-31 | −1,145.52% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2022 | 2022-03-31 | −1,673.50% | −1404.93 pp |
| Q2 2021 | 2021-06-30 | −234.37% | +89.70 pp |
| Q1 2021 | 2021-03-31 | −39.39% | +139.05 pp |
| Q4 2020 | 2020-12-31 | −218.89% | +433.39 pp |
| Q2 2015 | 2015-06-30 | −268.57% | +408.52 pp |
| Q1 2015 | 2015-03-31 | −324.07% | +221.21 pp |
| Q4 2014 | 2014-12-31 | −178.44% | +353.00 pp |
| Q3 2014 | 2014-09-30 | −652.28% | −63.14 pp |
| Q2 2014 | 2014-06-30 | −677.09% | — |
| Q1 2014 | 2014-03-31 | −545.28% | — |
| Q4 2013 | 2013-12-31 | −531.44% | — |
| Q3 2013 | 2013-09-30 | −589.15% | — |
Across the available reported history, SELLAS Life Sciences Group's operating margin decreased from −332.82% to −4,195.00%, a change of −3862.18 percentage points. The latest reported quarter, Q1 2022, shows −1,673.50%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review SELLAS Life Sciences Group filings at SEC.gov ↗